Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1991
05/29/1991EP0429245A2 A therapeutic agent for central nervous diseases
05/29/1991EP0429242A2 Specific binding agents
05/29/1991EP0428876A2 Method for the prevention and treatment of bovine mastitis
05/29/1991EP0428849A2 Retroviral protease inhibitors
05/29/1991EP0428758A1 Albumin preparation and method of producing the same
05/29/1991EP0428636A1 Use of interleukin 2 to treat endotoxinemia.
05/29/1991EP0428603A1 Cytotoxic agent against specific virus infection
05/29/1991DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation
05/29/1991DE3938953A1 Klonierung und expression des fuer die blut-hirn-schranke spezifischen proteins ht7 Cloning and expression of the for the blood-brain barrier-specific proteins HT7
05/29/1991CN1051757A Polypeptide compound and process for preparation thereof
05/29/1991CN1051732A Method for isolating biologically active compounds
05/28/1991US5019647 Antigrowth and anticarconogenic hexapeptide
05/28/1991US5019646 Polypeptides with fibronectin activity
05/28/1991US5019562 Growth inhibiting agent and the use thereof
05/28/1991US5019559 Wound healing using PDGF and IGF-II
05/28/1991US5019556 Human Placental Ribonuclease Inhibitor
05/28/1991US5019513 Anti-bacterial T-cell factor
05/28/1991US5019508 DNA Constructs
05/28/1991US5019385 Novel lymphopine LK 2 and pharmaceutic compositions containing same
05/28/1991US5019382 Treatment of immuno-resistant disease with low-dose interferon
05/28/1991US5019381 Method for lowering cholesterol levels using GM-CSF
05/28/1991US5019368 Antibody bound to antitumor agent
05/28/1991CA2030927A1 Fibrinolytic protein and production method thereof
05/28/1991CA2030850A1 Process for the purification of lipocortins
05/28/1991CA2030720A1 Hexapeptides with sulphate ester groups
05/28/1991CA1284550C Retro-inverso analogs of the bradykinin potentiating peptide bpp*in5a*xx
05/25/1991WO1991008222A1 Physiologically active substance be-16627
05/25/1991CA2045621A1 Physiologically active substance be-16627
05/25/1991CA2030770A1 Thrombolytic agents
05/23/1991WO1991007980A1 Compositions for treating ischemia-related neuronal damage
05/23/1991WO1991007188A1 Method for reducing blood cholesterol using arginine
05/23/1991DE3942728C1 New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
05/23/1991CA2069413A1 Method for reducing blood cholesterol using arginine
05/23/1991CA2069402A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
05/23/1991CA2030212A1 Peptides
05/22/1991WO1991007386A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
05/22/1991WO1991007186A1 Anti-inflammatory compositions and methods
05/22/1991EP0428486A1 Polymyxin conjugates
05/22/1991EP0428367A1 Isolation and structural elucidation of the cytostatic linear depsipetide dolastatin 14
05/22/1991EP0428267A2 Erythropoietin isoforms
05/22/1991EP0428266A1 Anticancer agent
05/22/1991EP0428107A2 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors
05/22/1991EP0428104A2 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
05/22/1991EP0427998A2 A pharmaceutical composition for rectal administration of calcitonin
05/22/1991EP0427912A1 Control of microbial growth with lantibiotic/lysozyme formulations
05/22/1991EP0427768A1 Polypeptide pertussis toxin vaccine
05/22/1991EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor
05/22/1991CN1051503A Treatment of conditions and disease
05/22/1991CN1012645B Production of protein
05/22/1991CA2069112A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
05/22/1991CA2069090A1 Anti-inflammatory compositions and methods
05/21/1991US5017691 Mammalian interleukin-4
05/21/1991US5017689 Analgesics
05/21/1991US5017688 Peptides involved in the pathogenesis of HIV infection
05/21/1991US5017583 Leukotriene antagonists
05/21/1991US5017567 Steroid antiinflammatory
05/21/1991US5017565 Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
05/21/1991US5017560 Porcine prolactin
05/21/1991US5017557 Treatment of infertility with somatotrophin releasing factor
05/21/1991US5017556 Treatment of bleeding disorders using lipid-free tissue factor protein
05/21/1991US5017489 Antibodies
05/21/1991US5017486 Cloning of DNA encoding antibacterial polypeptide precursor
05/21/1991US5017470 Hormones
05/21/1991US5017371 Method for reducing side effects of cancer therapy
05/21/1991US5017370 Improved method of performing angioplasty procedures
05/21/1991CA2030254A1 Methods of treating retroviral infection
05/18/1991WO1991007500A1 Specific binding agents
05/18/1991WO1991007490A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2135744A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2068728A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2066670A1 Specific binding agents
05/18/1991CA2030181A1 Therapeutic agent for central nervous diseases
05/17/1991WO1991007164A1 Cosmetic deodorants
05/17/1991CA2068410A1 Cosmetic deodorants
05/17/1991CA2030006A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin
05/16/1991WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/16/1991WO1991006858A1 Novel monoclonal antibody against human platelets
05/16/1991WO1991006668A1 Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
05/16/1991WO1991006658A2 Infective protein delivery system
05/16/1991WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991WO1991006639A1 Recombinant production of lactoperoxidase
05/16/1991WO1991006632A1 Inhibition of padgem-mediated cell binding
05/16/1991WO1991006575A1 Hiv-1 specific human monoclonal antibody
05/16/1991WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
05/16/1991WO1991006570A1 HYBRID Fc RECEPTOR MOLECULES
05/16/1991WO1991006569A1 Iodothyronine polymers
05/16/1991WO1991006568A1 High molecular weight human angiogenic factors
05/16/1991WO1991006567A1 M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them
05/16/1991WO1991006565A1 Physiologically active peptide
05/16/1991WO1991006560A1 Cross-linked tumour necrosis factors
05/16/1991WO1991006321A1 Use of honey as vaccine
05/16/1991WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
05/16/1991WO1991006311A1 Anti-viral material
05/16/1991WO1991006306A1 Antivenoms and methods for making antivenoms
05/16/1991WO1991006293A2 Composition containing 2,3-butanedione monoxime and method for reversibly arresting muscle activity
05/16/1991WO1991004728A3 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
05/16/1991WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast
05/16/1991DE4036130A1 New phosphonamide-contg. polypeptide derivs. - useful as bacterial collagenase inhibitors to treat gangrene and periodontal disease
05/16/1991DE4035456A1 Pharmaceutical composition
05/16/1991DE3937607A1 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen Use of an anticoagulant in the treatment of tumor diseases